Enhanced blood–brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider

References

• Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release 2012;161:264–73.
   PubMed Web of Science ®Google Scholar
• Ding JJ, Li JF, Mao SR. Development and evaluation of vinpocetine inclusion complex for brain targeting. Asian J Pharm Sci 2015;10:114–20.
   Web of Science ®Google Scholar
• Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 2012;64:640–65.
   PubMed Web of Science ®Google Scholar
• Francis MF, Cristea M, Winnik FM. Polymeric micelles for oral drug delivery, why and how. Pure Appl Chem 2004;76:1321–35.
   Web of Science ®Google Scholar
• Tian Y, Mao S. Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs. Expert Opin Drug Deliv 2012;9:687–700.
   PubMed Web of Science ®Google Scholar
• Silva A, González-Mira E, Lobo JS, Amaral M. Current progresses on nanodelivery systems for the treatment of neuropsychiatric diseases: alzheimer’s and schizophrenia. Curr Pharm Design 2013;19:7185–95.
   PubMed Web of Science ®Google Scholar
• Tian Y, Shi C, Zhang X, et al. Nanomicelle based peroral delivery system for enhanced absorption and sustained release of 10-hydrocamptothecin. J Biomed Nanotechnol 2015;11:262–73.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma W, Tu P. The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivo. Colloids Surf B Biointerfaces 2015;133:108–19.
   PubMed Web of Science ®Google Scholar
• Mathot F, des Rieux A, Ariën A, et al. Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier. J Control Release 2007;124:134–43.
   PubMed Web of Science ®Google Scholar
• Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRx 2005;2:108–19.
   PubMedGoogle Scholar
• Morsi NM, Ghorab DM, Badie HA. Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization. Pharm Dev Technol 2013;18:736–44.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shi Y, Chen YZ, et al. Enhanced antitumor efficacy by Paclitaxel-loaded Pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur J Pharm Biopharm 2010;75:341–53.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li LB, Zhai GX. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces 2008;64:194–9.
   PubMed Web of Science ®Google Scholar
• Ebrahim-Attia AB, Ong ZY, Hedrick JL, et al. Mixed micelles self-assembled from block copolymers for drug delivery. Curr Opin Colid In 2011;16:182–94.
   Web of Science ®Google Scholar
• Gao ZG, Fain HD, Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release 2005;102:203–22.
   PubMed Web of Science ®Google Scholar
• Sezgin Z, Yuksel N, Baykara T. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Int J Pharm 2007;332:161–7.
   PubMed Web of Science ®Google Scholar
• Sweet DM, Kolhatkar RB, Ray A, et al. Transepithelial transport of PEGylated anionic poly (amidoamine) dendrimers, implications for oral drug delivery. J Control Release 2009;138:78–85.
   PubMed Web of Science ®Google Scholar
• Suk JS, Lai SK, Boylan NJ, et al. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine 2011;6:365–75.
   PubMed Web of Science ®Google Scholar
• Cai Z, Hou SX, Li YB, et al. Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target 2008;16:178–84.
   PubMed Web of Science ®Google Scholar
• Zhang L, Han L, Qin J, et al. The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain. Pharm Res 2013;30:2560–72.
   PubMed Web of Science ®Google Scholar
• Ribeiro L, Loftsson T, Ferreira D, Veiga F. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes. Chem Pharm Bull 2003;51:914–22.
   PubMed Web of Science ®Google Scholar
• Grandt R, Beitinger H, Schaltenbrand R, Wraun B. Vinpocetine pharmacokinetics in elderly subjects. Arzneimittelforschung 1989;39:1599–602.
   PubMed Web of Science ®Google Scholar
• Wei Z, Hao J, Yuan S, et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles, formulation, optimization and in vitro characterization. Int J Pharm 2009;376:176–85.
   PubMed Web of Science ®Google Scholar
• Aguiar J, Carpena P, Molina-Bolıvar J, Carnero RC. On the determination of the critical micelle concentration by the pyrene 1,3 ratio method. J Colloid Interf Sci 2003;258:116–22.
   Web of Science ®Google Scholar
• Nie SF, Fan XW, Peng Y, et al. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin. Arch Pharm Res 2007;30:991–1001.
   PubMed Web of Science ®Google Scholar
• Lin CC, Chen F, Ye TT, et al. A novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug, Vinpocetine. Int J Pharm 2014;465:90–6.
   PubMed Web of Science ®Google Scholar
• Poda AR, Bednar AJ, Kennedy AJ, et al. Detection and characterization of silver nanoparticles in aqueous matrices using asymmetric-flow field flow fractionation with inductively coupled plasma mass spectrometry. J Chromatogr A 2011;1218:4219–25.
   PubMed Web of Science ®Google Scholar
• Chaibundit C, Ricardo NM, Costa FMLL, et al. Micellization and gelation of mixed copolymers P123 and F127 in aqueous solution. Langmuir 2007;23:9229–36.
   PubMed Web of Science ®Google Scholar
• Chiappetta DA, Sosnik A. Poly (ethylene oxide)–poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 2007;66:303–17.
   PubMed Web of Science ®Google Scholar
• Bastakoti BP, Inuoe M, Yusa SI, et al. A block copolymer micelle template for synthesis of hollow calcium phosphate nanospheres with excellent biocompatibility. Chem Commun 2012;48:6532–4.
   PubMed Web of Science ®Google Scholar
• Kulthe SS, Inamdar NN, Choudhari YM, et al. Mixed micelle formation with hydrophobic and hydrophilic pluronic block copolymers, implications for controlled and targeted drug delivery. Colloid Surf B 2011;88:691–6.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev 2002;54:235–52.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao Y, Allen C. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci 2004;93:132–43.
   PubMed Web of Science ®Google Scholar
• Li JZ, Chen F, Hu CJ, et al. Optimized preparation of in situ forming microparticles for the parenteral delivery of vinpocetine. Chem Pharm Bull 2008;56:796–801.
   PubMed Web of Science ®Google Scholar
• Vas Á, Gulyás B, Szabó Z, et al. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine. A summary of evidences. J Neurol Sci 2002;203:259–62.
   PubMed Web of Science ®Google Scholar
• Mária AD. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 2009;1788:892–910.
   PubMed Web of Science ®Google Scholar
• Yu B, Ruan M, Dong X, et al. The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. J Ethnopharmacol 2013;150:1096–108.
   PubMed Web of Science ®Google Scholar
• Yang H, Xun Y, Li Z, et al. Influence of borneol on in vitro corneal permeability and on in vivo and in vitro corneal Toxicity. J Int Med Res 2009;37:791–802.
   PubMed Web of Science ®Google Scholar
• Jin D, Wang F, Qu LJ, et al. The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment. Mol Biol Rep 2011;38:913–20.
   PubMed Web of Science ®Google Scholar
• Chen YM, Wang NS. Effect of borneol on P-glycoprotein. Tradit Chin Drug Res Clin Pharmacol 2003;14:96–9.
   Google Scholar
• Zhou YQ, Li WZ, Chen LY, et al. Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro. Environ Toxicol Pharmacol 2010;29:229–34.
   PubMed Web of Science ®Google Scholar